Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice

被引:13
|
作者
Ye, Yumei [1 ]
Nylander, Sven [2 ]
Birnbaum, Yochai [3 ]
机构
[1] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA
[2] AstraZeneca R&D, Molndal, Sweden
[3] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
关键词
Aspirin; Statin; Ticagrelor; Clopidogrel; Adenosine; Atherosclerosis; Inflammation; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; LOW-DOSE ASPIRIN; RECEPTOR-DEFICIENT MICE; CYTOKINE-CHEMOKINE AXIS; MYOCARDIAL-INFARCTION; INDUCED CARDIOPROTECTION; NEUTROPHIL RESPONSES; ANTIPLATELET THERAPY; 15-EPI-LIPOXIN A(4);
D O I
10.1007/s10557-017-6763-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We explored the effects of rosuvastatin, aspirin, ticagrelor, and clopidogrel, alone or in combinations on the progression of atherosclerosis and inflammasome activation in diabetic mice. Statins and ticagrelor increase the production of 15-epi-lipoxin A(4) via cyclooxygenase-2. Aspirin alone increases 15-epi-lipoxin A(4), but when combined with statins, cyclooxygenase-2 is completely blocked. ApoE(-/-)/db(+)/db(+) double-knockout mice received rosuvastatin (5 mg/kg/day), aspirin (25 mg/kg/day), ticagrelor (300 mg/kg/day), clopidogrel (75 mg/kg/day), or their combination for 14 weeks. Serum 15-epi-lipoxin A(4) levels and aortic wall cholesterol content, IL-1 beta, IL-6, and TNF-alpha levels, and plaque area were assessed. Aspirin, ticagrelor, and rosuvastatin increased 15-epi-lipoxin A(4) levels. The combination of rosuvastatin + ticagrelor provided an additive effect. Aspirin attenuated the effect of both ticagrelor and rosuvastatin. Aspirin, ticagrelor, and rosuvastatin reduced the area of the atherosclerotic plaque. The combination of ticagrelor + rosuvastatin provided additive effects. There was a negative interaction when aspirin was combined with ticagrelor or rosuvastatin. Aspirin, ticagrelor, and rosuvastatin decreased serum IL-1 beta and IL-6 levels. There was no interaction between aspirin and ticagrelor or aspirin and rosuvastatin, whereas combining rosuvastatin and ticagrelor provided an additive effect. Aspirin, ticagrelor, and rosuvastatin all decreased TNF-alpha levels. Aspirin attenuated the effect of both ticagrelor and rosuvastatin, and there was no additive effect of combining ticagrelor + rosuvastatin. We found an intricate interaction between aspirin, ticagrelor, and rosuvastatin, as aspirin reduced both ticagrelor and rosuvastatin ability to ameliorate inflammation and atherosclerosis. In contrast, we found additive effects when ticagrelor and rosuvastatin were combined.
引用
收藏
页码:489 / 500
页数:12
相关论文
共 50 条
  • [21] Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice
    Tsilimigras, Diamantis I.
    Thanopoulou, Kalliopi
    Salagianni, Maria
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Perrea, Despina D.
    Nirakis, Nikolaos
    Filis, Konstantinos
    Tsioufis, Konstantinos
    Tousoulis, Dimitrios
    Sigala, Fragiska
    IN VIVO, 2023, 37 (03): : 994 - 1002
  • [22] PSRC1 overexpression attenuates atherosclerosis progression in apoE-/- mice by modulating cholesterol transportation and inflammation
    Guo, Kai
    Hu, Lu
    Xi, Dan
    Zhao, Jinzhen
    Liu, Jichen
    Luo, Tiantian
    Ma, Yusheng
    Lai, Wenyan
    Guo, Zhigang
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 116 : 69 - 80
  • [23] Effects and related mechanism of retinoid X receptor agonist bexarotene on atherosclerosis progression in diabetic apoE-/- mice
    祝江
    China Medical Abstracts(Internal Medicine), 2014, 31 (03) : 159 - 160
  • [24] Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: Implication for plaque progression in diabetic atherosclerosis
    Purushothaman, K-Raman
    Purushothaman, Meerarani
    Muntner, Paul
    Lento, Patrick A.
    O'Connor, William N.
    Sharma, Samin K.
    Fuster, Valentin
    Moreno, Pedro R.
    VASCULAR MEDICINE, 2011, 16 (02) : 103 - 108
  • [25] Macrophage-specific Ripk1 Knockdown Reduces Macrophage Inflammation And Atherosclerosis Progression In Ldlr-/- Mice
    Xu, Han
    Caceres, Felipe Tapia
    Eng, Vik
    Wang, Yizhuo
    Bisht, Kavita
    Cochran, Blake
    Rye, Kerry Anne
    Karunakaran, Denuja
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [26] Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, suppresses the progression of atherosclerosis in diabetic apoE-deficient mice
    Murakami, Saiko
    Matsumura, Takeshi
    Senokuchi, Takafumi
    Ishii, Norio
    Fukuda, Kazuki
    Yamada, Sarie
    Morita, Yutaro
    Nishida, Shuhei
    Sato, Miki
    Motoshima, Hiroyuki
    Kondo, Tatsuya
    Araki, Eiichi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S99 - S99
  • [27] Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
    A. M. D. Watson
    A. Soro-Paavonen
    K. Sheehy
    J. Li
    A. C. Calkin
    A. Koitka
    S. N. Rajan
    D. Brasacchio
    T. J. Allen
    M. E. Cooper
    M. C. Thomas
    K. J. A. Jandeleit-Dahm
    Diabetologia, 2011, 54 : 681 - 689
  • [28] Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
    Watson, A. M. D.
    Soro-Paavonen, A.
    Sheehy, K.
    Li, J.
    Calkin, A. C.
    Koitka, A.
    Rajan, S. N.
    Brasacchio, D.
    Allen, T. J.
    Cooper, M. E.
    Thomas, M. C.
    Jandeleit-Dahm, K. J. A.
    DIABETOLOGIA, 2011, 54 (03) : 681 - 689
  • [29] EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation
    Ha, Kyung Bong
    Sangartit, Weerapon
    Jeong, Ah Reum
    Lee, Eun Soo
    Kim, Hong Min
    Shim, Soyeon
    Kukongyiriyapan, Upa
    Kim, Dae-Kee
    Lee, Eun Young
    Chung, Choon Hee
    ENDOCRINOLOGY AND METABOLISM, 2022, 37 (01) : 96 - 111
  • [30] Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice
    Xuemei Wang
    Qingjie Chen
    Hongwei Pu
    Qin Wei
    Mingjun Duan
    Chun Zhang
    Tao Jiang
    Xi Shou
    Jianlong Zhang
    Yining Yang
    Lipids in Health and Disease, 15